Endogeny Bio Corp.
This article was originally published in Start Up
Executive Summary
Endogeny Bio hopes to exploit the newly discovered regenerative properties of the heart to develop protein therapeutics and small molecules drugs that activate a patient's own multipotential cells to repair damaged heart muscle.